Activation of protease-activated receptor1 mediates induction of matrix metalloproteinase-9 by thrombin in rat primary astrocytes

被引:41
作者
Choi, Min Sik [1 ]
Kim, Young Eun [1 ]
Lee, Woo Jong [1 ]
Choi, Ji Woong [1 ]
Park, Gyu Hwan [1 ]
Kim, Sun Don [1 ]
Jeon, Se Jin [1 ]
Go, Hyo Sang [1 ]
Shin, Sun Mi [1 ]
Kim, Won-Ki [2 ]
Shin, Chan Young [3 ,4 ]
Ko, Kwang Ho [1 ]
机构
[1] Seoul Natl Univ, Dept Pharmacol, Coll Pharm, Seoul 151742, South Korea
[2] Korea Univ, Coll Med, Dept Neurosci, Seoul 136705, South Korea
[3] Konkuk Univ, Sch Med, Ctr Geriatr Neurosci Res, Inst Biomed Sci, Seoul, South Korea
[4] Konkuk Univ, Sch Med, Dept Pharmacol, Seoul, South Korea
关键词
thrombin; MMP-9; PAR1; rat primary astrocytes; Erk1/2;
D O I
10.1016/j.brainresbull.2008.02.031
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Thrombin plays an important role in diverse neurological processes such as proliferation, cell migration, differentiation and neuroinflammation. In this study, we investigated the effect of thrombin on matrix metalloprotease-9 (MMP-9) expression in rat primary astrocytes. Thrombin (1-10 U/ml) induced a significant increase in MMP-9 activity as measured by gelatin zymography. Thrombin also increased MMP-9 mRNA expression. Among three isotypes of thrombin receptor, i.e. protease-activated receptor (PAR)-1, -3 and -4, PAR1 agonist (1-100 mu M) but not PAR3 and PAR4 agonist induced MMP-9 expression. Inhibition of thrombin-induced MMP-9 production by SCH 79797 (10-50 nM), a selective PARI receptor antagonist, confirmed that PAR1 is a main receptor for thrombin-induced MMP-9 expression. In astrocytes, thrombin activated Erk1/2, and it was inhibited by PD98059. In this study, thrombin-induced MMP-9 expression was inhibited by PD98059. PAR1 agonist activated Erk1/2 and PD98059 inhibited PAR1 agonist-induced MMP-9 expression. MMP-9 promoter reporter assay confirmed the positive effect of ERK1/2 on MMP-9 expression. These results suggest that the activation of PAR1 mediates thrombin-induced MMP-9 expression through the regulation of Erk1/2. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:368 / 375
页数:8
相关论文
共 56 条
[1]   Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS [J].
Anthony, DC ;
Miller, KM ;
Fearn, S ;
Townsend, MJ ;
Opdenakker, G ;
Wells, GMA ;
Clements, JM ;
Chandler, S ;
Gearing, AJH ;
Perry, VH .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 87 (1-2) :62-72
[2]   Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes [J].
Arai, K ;
Lee, SR ;
Lo, EH .
GLIA, 2003, 43 (03) :254-264
[3]   Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia [J].
Asahi, M ;
Wang, XY ;
Mori, T ;
Sumii, T ;
Jung, JC ;
Moskowitz, MA ;
Fini, ME ;
Lo, EH .
JOURNAL OF NEUROSCIENCE, 2001, 21 (19) :7724-7732
[4]   Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson's disease [J].
Cannon, Jason R. ;
Keep, Richard F. ;
Schallert, Timothy ;
Hua, Ya ;
Richardson, Rudy J. ;
Xi, Guohua .
BRAIN RESEARCH, 2006, 1116 :177-186
[5]   Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson's disease model [J].
Cannon, JR ;
Keep, RF ;
Hua, Y ;
Richardson, RJ ;
Schallert, T ;
Xi, GH .
NEUROSCIENCE LETTERS, 2005, 373 (03) :189-194
[6]   Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain [J].
Cao, JA ;
Rehemtulla, A ;
Bahou, W ;
Zucker, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) :30174-30180
[7]   Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo:: Role of microglial NADPH oxidase [J].
Choi, SH ;
Lee, DY ;
Kim, SU ;
Jin, BK .
JOURNAL OF NEUROSCIENCE, 2005, 25 (16) :4082-4090
[8]  
Choi SH, 2003, J NEUROSCI, V23, P5877
[9]   Thrombin signalling and protease-activated receptors [J].
Coughlin, SR .
NATURE, 2000, 407 (6801) :258-264
[10]  
Debeir T, 1996, J NEUROCHEM, V66, P2320